Strategic Implications of Innovative, Technological and Market Trends for the US Diagnostics Market

Date: April 17, 2012
Pages: 135
Price:
US$ 4,850.00 US$ 4,122.50
License [?]:
Publisher: VPGMarketResearch.com
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: U77C05F08C2EN
Leaflet:

Download PDF Leaflet

Strategic Implications of Innovative, Technological and Market Trends for the US Diagnostics Market
  • How will the future reimbursement changes affect individual market segments?
  • Will the industry consolidate, decentralize, or undergo a bimodal transformation?
  • What will be the impact on purchasing influences, marketing strategies, joint ventures, mergers, licensing, import and export?
  • How will the future technological advances affect the major market segments?
  • Which companies will enter the market and which will not survive?
These and other key strategic issues facing decision-makers are explored in this thought-provoking and multi-faceted portrait of the future U.S. in vitro diagnostics market.

This invaluable strategic planning resource is designed to help corporate, marketing and R&D executives develop effective business plans that best accommodate uncertainties ahead. The report evaluates emerging markets and technologies that may present unexpected threats or offer opportunities; identifies key strategic decisions that will have to be made in the future; and enhances corporate ability to develop realistic contingency plans.

The report presents strategic overview of the U.S. in vitro diagnostics market, including major regulatory, economic, demographic and social trends with potentially significant impact; as well as five- and ten-year test volume and sales forecasts for major testing locations (hospitals, commercial labs, physician offices, blood centers, POC sites, and others) and laboratory disciplines (blood banking, clinical chemistry, immunodiagnostics, coagulation, hematology, flow cytometry, histology, cytology, microbiology, serology, urinalysis and others).

Contains 135 pages and 11 tables.
1. EXECUTIVE SUMMARY

2. CONCLUSIONS AND RECOMMENDATIONS

3. BUSINESS ENVIRONMENT

a. Health Care Expenditures
b. Cost-Consciousness
c. Reimbursement
d. Industry Consolidation
e. Hospitals
f. Admissions
g. Length of Stay
h. Industry Diversification
i. Physician Demographics
j. Aging Population
  More Chronic Illnesses
  Higher Incidence of Disease
  Greater Susceptibility to Iatrogenesis
  More Cases with Multiple Illnesses

4. OUTLOOK FOR THE IN VITRO DIAGNOSTICS MARKET

a. Government Regulations
b. FDA Reform
c. Hospitals
d. Commercial Laboratories
e. Physician Offices
f. Point-of-Care Testing
g. Personal Testing
h. Other Testing Locations

5. STRATEGIC IMPLICATIONS

a. Testing Patterns
  Test Utilization
  Pre-Admission Testing
  Inpatient Testing
  Outpatient Testing

6. MARKET SEGMENTS

a. Clinical Chemistry and Immunodiagnostics
  Introduction
  Future Situation
b. Microbiology and Serology
  Introduction
  Future Situation
c. Hematology and Flow Cytometry
  Introduction
  Future Situation
d. Blood Banking
  Introduction
  Future Situation
e. Histology and Cytology
  Introduction
  Future Situation
f. Coagulation
  Introduction
  Future Situation
g. Urinalysis
  Introduction
  Future Situation

7. TECHNOLOGIES

a. Molecular Diagnostics
  Introduction
  Future Situation
b. Monoclonal Antibodies
  Introduction
  Future Situation
c. Solid Phase Chemistry
  Introduction
  Future Situation
d. Biosensors and Biochips
  Introduction
  Future Situation
e. Automation and Robotics
  Introduction
  Future Situation
f. IT
  Introduction
  Future Situation

8. THE NEW MARKETPLACE

a. Purchasing Influences
b. Marketing Strategies
c. Joint Venture, Merger, and Licensing Activity
d. Import-Export
e. Potential Market Entrants
f. Who May Not Survive?

LIST OF TABLES

Executive Summary Table: Growth Areas in Clinical Laboratory Testing
Table-1: Estimated U.S. Health Care Expenditures By Expenditure Type
Table-2: Health Plan Enrollment Distribution
Table-3: Selected Hospital Statistics
Table-4: Total Population And Physician Demographics
Table-5: Test Volume By Location
Table-6: Test Distribution By Location
Table-7: Market Size By Location
Table-8: Typical Pre-Admission Tests
Table-9: Test Volume By Laboratory Discipline
Table-10: Market Size By Laboratory Discipline
Skip to top


Ask Your Question

Strategic Implications of Innovative, Technological and Market Trends for the US Diagnostics Market
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: